ProScribe’s recent merger with Envision Pharma Group allows ProScribe to offer our clients greater geographic reach, additional resources, and a wider range of services (eg, market access, medical affairs, and publication software [Datavision] and audits). ProScribe provides outstanding medical communication services to many of the leading international names in pharmaceuticals, biotechnology and academia. ProScribe specialises in writing scientifically credible, high quality documents. ProScribe's PhD Medical Writers comply with international medical writing guidelines and have extensive industry and academic experience, across a wide range of therapeutic areas. For more information, please visit www.proscribe.com.au